Author Description

Published annually to provide the most current IV drug information possible, the 2005 edition of Intravenous Medications is updated throughout with hundreds of new drug facts and approximately 10 new monographs for IV drugs recently approved by the FDA. More than 350 drug monographs are presented alphabetically by generic name in a clinically useful format. Each monograph heading includes the drug’s generic name, pronunciation, trade name(s), drug category, and pH. Monograph sections include: usual dose; pediatric dose; infant and/or neonatal dose; dose adjustments; dilution, including storage; compatibilities; incompatibilities; rate of administration; actions; indications and uses; contraindications; precautions, including monitor, patient education, maternal/child, and elderly; drug/lab interactions; side effects; and antidote. All drugs are listed in the index by generic and common trade names, as well as by pharmacologic action. Appendixes offer useful information on handling cytotoxic drugs, alternate choices for infrequently used drugs, FDA pregnancy categories, information for patients receiving immunosuppressive agents, and National Cancer Institute common toxicity grading criteria. Established as the bestselling IV drug reference for over 30 years - trusted for its accuracy and comprehensive coverage. Offers coverage of more than 350 IV drugs providing an unparalleled drug reference for clinicians in any setting. Displays dosing information on a single page or a two-page spread to ensure that the clinician does not contaminate his or her hands by having to turn the page. Includes over 100 charts detailing dosing and dilution guidelines, recommended dose modifications, combination schedules, infusion rates, and more. Monograph subsection identifies established uses of a drug that do not appear on the label to alert clinicians to off-label treatments or procedures for which a drug may be used. Comprehensive, alphabetic index lists drugs by generic name, trad